Deutsche Bank Comments on How Biogen Idec May be Affected by Tecfidera IMS Data - Biogen (NASDAQ:BIIB)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

In a report published Friday, Deutsche Bank analyst Robyn Karnauskas reiterated a Buy rating and $340.00 price target on

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Biogen Idec

(NASDAQ: BIIB).In the report, Deutsche Bank noted, “Our calculations on IMS data for Tecfidera for week ending 11/22 indicate strong Tecfidera at $363M-$365M in Q4'13. For FY 2013, our calculations based on IMS data indicate Tecfidera US sales at $839M-$841M. Consensus is expecting 4Q sales at $338M while 2013 sales at $807M in the US. Please ask for our detailed analysis of IMS scripts. Trx were down 1% at 4,967 vs. 5,026 last wk, Nrx were down 3% at 1,805 vs. 1,862 last week.”Biogen Idec closed on Wednesday at $293.83.